Advertisement
Screener

Five Prime Therapeutics, Inc. Form 10-K/A: Amended annual report

Five Prime Therapeutics, Inc. Form 10-K/A: Amended annual report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2018-03-12: Form 10-K/A; Period of report 2017-12-31; Description 10-K/A; Document d547895d10ka.htm.
FiledFormPeriod of reportDescriptionDocument
2018-03-1210-K/A2017-12-3110-K/Ad547895d10ka.htm